MedTrace Logo

COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial

NCT03214029 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-10-09

No results posted yet for this study

Summary

Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.

Conditions

  • Acute Myocardial Infarction
  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Cardiac troponin testing

Fresh EDTA plasma samples will be measured with both the hs-cTnI (Abbott) and hs-cTnT (Roche) assays.

Sponsors & Collaborators

  • Abbott Diagnostics Division

    collaborator INDUSTRY

  • Hennepin County Medical Center, Minneapolis

    collaborator OTHER

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Fred S Apple, PhD · Hennepin County Medical Center and Minneapolis Medical Research Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-06
Primary Completion
2022-12-31
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03214029 on ClinicalTrials.gov